Randomized, Open Label, Phase III Trial of Figitumumab in Combination with Paclitaxel and Carboplatin versus Paclitaxel and Carboplatin in Patients with.
Gastrointestinal Colorectal Cancer Poster Discussion Session #3523 - #3528 Josep Tabernero, MD Vall d’Hebron University Hospital Barcelona, Spain.
Gastrointestinal Colorectal Cancer Poster Discussion Session #3523 - #3528